Company
Nexus Dx is a dynamic new clinical diagnostics company working to improve patient care by providing the medical community with rapid and reliable information at Point of Care (POC). Initial products include both qualitative and quantitative cardiac assays.
“Nexus Dx Mission is to enhance health and well being of people around the Globe by providing quality test information when and where it is most needed.”
Our Vision is to rapidly become a top tier worldwide POC diagnostic leader through unique solutions created via internal development, partnerships and acquisitions.
INVESTMENT HIGHLIGHTS
Nexus Dx is a consolidator in the point of care diagnostics industry having a multi-product revenue generating business. It uses proprietary technology and content and is driven by a highly experienced management team. This is combined with the backing of a strong investor syndicate consisting of Bay City Capital, Kleiner Perkins Caufield & Byers and Prolog Ventures.